Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 29, 1999 - Issue 6
45
Views
1
CrossRef citations to date
0
Altmetric
Research Article

In vitro effects of racemates, separate enantiomers and major metabolites of mefloquine and halofantrine on metoprolol biotransformation by rat liver microsomes

, , &
Pages 595-601 | Published online: 22 Sep 2008

References

  • BRYSON, H. M. and GOA, K. L., 1992, Halofantrine: a review of its anti-malarial activity, pharmaco-kinetic properties and therapeutic potential. Drugs, 43, 236–258.
  • CARROLL, F. I., BERRANG, B. and LINN, C. P., 1978, Resolution and anti-malarial agents via complex formation with a-(2,4,5,7-tetranitro-9-fluorenylideneaminooxy) propionic acid. Journal of Medicinal Chemistry, 21, 326–330.
  • CARROLL, F. I. and BLACKWELL, J. T., 1974, Optical of aryl-2-piperidyl methanol anti-malarial agents. Preparation, optical purity and absolute stereochemistry. Journal of Medicinal Chemistry, 17, 210–219.
  • GIMENEZ, F., AUBRY, A. F., FARINOTTI, R., KIRKLAND, K. and WAINER, I. W., 1992, The determination of the enantiomers of halofantrine and monodesbutylhalofantrine in plasma and whole blood using a sequential achiral-chiral high performance liquid chromatography. Journal of Pharma-ceutical and Biomedical Analysis, 10, 245–250.
  • GIMENEZ, F., FAIUNOTTI, R., THUILL1ER, A., HAZEBROUCQ, G. and WAINER, I. W., 1990, Determination of the enantiomers of mefloquine in plasma and whole blood using a coupled achiral-chiral high-performance liquid chromatographic system. Journal of Chromatography, 259, 339–346.
  • HALLIDAY, R. C., Jos, B. C., SMITH, D. A., KITTERINCHAM, N. R. and PARK, B. K., 1995, An investigation of the interaction between halofantrine, CYP 2D6 and CYP 3A4, studies with human liver microsomes and heterologous enzyme expression systems. British Journal of Clinical Pharmacology, 40, 369–378.
  • KARBWANG, J. and NA BANGCHANG, K., 1994, Clinical of halofantrine. Clinical Pharmacokinetics, 27, 104–119.
  • LANCASTER, D. L., ADIO, R. A., TAI, K. K., SIMMOYA, 0.0., BROADHEAD, G. D., TUCKER, G. T. and LENNARD, M. S., 1990, Inhibition of metoprolol metabolism by chloroquine and other anti-malarial drugs. Journal of Pharmacy and Pharmacology, 42, 267–271.
  • LARRY, D., DISTERLATH, L. M., DANNAN, G. A., WILKINSON, G. R. and GUENGERICH, F. P., 1984, Purification of the rat liver microsomal cytochrome P-450 involved in the 4 hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. Biochemistry, 23, 2787–2795.
  • LENNARD, M. S., 1985, Quantitative analysis of metoprolol and three of its metabolites in urine and liver microsomes by high-performance liquid chromatography. Journal of Chromatography, 342, 199–205.
  • LENNARD, M. S., CREWE, H. K., TUCKER, G. T. and WOODS, H. F., 1986, Metoprolol oxidation by rat liver microsomes inhibition by debrisoquine and other drugs. Biochemical Pharmacology, 35, 2757–2761.
  • MIHALY, G. W., WARD, S. E., NICHOLL, D. D., EDWARDS, G. and BRECICENRIDGE, M., 1985, The effects of primaquine stereoisomers and metabolites on drug metabolism in the isolated perfused rat liver and in vitro rat liver microsomes. Biochemical Pharmacology, 34, 331–336.
  • PALMER, K. J., HOLLIDAY, S. M. and BROGDEN, R. N., 1993, Mefloquine : a review of its anti-malarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs, 45, 430–475.
  • SEGEL, I. H., 1975, Enzyme Kinetics: Behaviour and Analysis of Rapid Equilibrium and Steady-state Enzyme Systems (New York: John Wiley).
  • WHITE, N. J., 1985, Clinical pharmacokinetics of anti-malarial drugs. Clinical Pharmacokinetics, 10, 187–215.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.